2nd Quarter - Amendment

VAN HEUVELEN STRATEGIES, LLC for ALLERGAN PLC (FORMERLY KNOWN AS ACTAVIS)

Firm
Client
Income
$50,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Jul 21, 2014 $40,000 Replaced
2nd Quarter - Amendment (this page) Oct 14, 2014 $50,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Prescription drug user fee act and other issues related to generic drugs H.R. 325 - No Budget, No Pay Act of 2013 H.R. 3204 - Drug Quality and Security Act H.R. 3309 - Innovation Act S. 1013 - Patent Abuse Reduction Act of 2013 S. 1612 - Patent litigation and Integrity Act of 2013 S. 1720 - Patent Transparency and Improvements Act of 2013 S. 2049 - Transparency in Assertion of Patents Act S. Con. Res. 8 - FY 2014 Budget Resolution

LobbyistCovered position, as disclosed
ROBERT VAN HEUVELEN Chief of Staff to Senator Kent Conrad
STEPHEN DOUGLAS WARD Chief of Staff to Senator Jeff Bingaman

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1720 (113th), S. 2049 (113th), S. 1013 (113th), H.R. 3309 (113th), H.R. 325 (113th), S. 1612 (113th), S.Con.Res. 8 (113th), H.R. 3204 (113th)

Health Issues HCR

Prescription drug user fee act and other issues related to generic drugs H.R. 325 - No Budget, No Pay Act of 2013 H.R. 3204 - Drug Quality and Security Act H.R. 3309 - Innovation Act S. 1013 - Patent Abuse Reduction Act of 2013 S. 1612 - Patent litigation and Integrity Act of 2013 S. 1720 - Patent Transparency and Improvements Act of 2013 S. 2049 - Transparency in Assertion of Patents Act S. Con. Res. 8 - FY 2014 Budget Resolution

LobbyistCovered position, as disclosed
ROBERT VAN HEUVELEN Chief of Staff to Senator Kent Conrad
STEPHEN DOUGLAS WARD Chief of Staff to Senator Jeff Bingaman

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1720 (113th), S. 2049 (113th), H.R. 3309 (113th), S.Con.Res. 8 (113th), H.R. 325 (113th), S. 1013 (113th), H.R. 3204 (113th), S. 1612 (113th)

Labor Issues/Antitrust/Workplace LBR

Prescription drug user fee act and other issues related to generic drugs H.R. 325 - No Budget, No Pay Act of 2013 H.R. 3204 - Drug Quality and Security Act H.R. 3309 - Innovation Act S. 1013 - Patent Abuse Reduction Act of 2013 S. 1612 - Patent litigation and Integrity Act of 2013 S. 1720 - Patent Transparency and Improvements Act of 2013 S. 2049 - Transparency in Assertion of Patents Act S. Con. Res. 8 - FY 2014 Budget Resolution

LobbyistCovered position, as disclosed
ROBERT VAN HEUVELEN Chief of Staff to Senator Kent Conrad
STEPHEN DOUGLAS WARD Chief of Staff to Senator Jeff Bingaman

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S.Con.Res. 8 (113th), S. 1612 (113th), H.R. 3204 (113th), H.R. 325 (113th), S. 1013 (113th), S. 2049 (113th), S. 1720 (113th), H.R. 3309 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.